相关实验视频
Updated: Jun 4, 2025

07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
12.8K
心脏的基因疗法:封装病毒来救援
Uma Maheswari Deshetty1, Susmita Sil1, Shilpa Buch1
1Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA.
Extracellular vesicles and circulating nucleic acids
|December 19, 2024
概括
细胞外囊泡封装的腺相关病毒 (EV-AAVs) 显示出增强基因传递到心脏细胞的潜力,克服抗体抵抗. 这种方法提高了治疗基因传递的有效性,特别是在缺血性心脏病中.
科学领域:
- 心血管研究研究心血管研究
- 基因治疗 基因治疗
- 纳米医学是一种纳米医学.
背景情况:
- 腺相关病毒 (AAV) 广泛用于基因疗法,但面临诸如中和抗体 (NAbs) 等挑战.
- 心肌细胞 (CMs) 是治疗心脏病的关键点,但有效的基因传递仍然很困难.
- 细胞外囊泡 (EVs) 为治疗剂提供了潜在的替代输送载体.
研究的目的:
- 分析细胞外囊泡封装AAVs (EV-AAVs) 对向心肌细胞传递基因的疗效.
- 为了评估EV-AAV对AAV中和抗体 (NAbs) 的耐药性.
- 评估EV-AAVs在改善对缺血性心脏的基因传递方面的潜力.
主要方法:
- 从产生AAV-6和AAV-9的HEK293T细胞中隔离EVs.
- 在体外和体外模型中对EV-AAV和自由AAV进行比较.
- 在NAbs的存在下对基因传递有效性的评估.
主要成果:
- 与自由AAV相比,EV-AAV对NAbs的抵抗性增加.
- 通过EV-AAVs观察到对心肌细胞的增强基因传递疗效.
- 在缺血性心脏模型中改善治疗结果的潜力.
结论:
- EV封装是一种有前途的策略,可以增强AAV介导的基因传递到心脏.
- 这种方法可以克服NAb介导的障碍,提高治疗基因转移效率.
- 需要进一步的研究来探索EV-AAV在心脏基因治疗中的全部潜力.
相关概念视频
Gene Therapy
25.2K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.2K
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

